Lithium safety and tolerability in mood disorders: A critical review;Tolerabilidade e segurança do lítio em transtornos do humor: Uma revisão crítica

Revista de Psiquiatria Clinica

Volumn 41, Issue 1, 2014, Pages 9-14

  Aprahamian, Ivan ^a   De Sousa, Rafael Teixeira ^a   Da Valiengo, Leandro Costa Lane ^a   Machado Vieira, Rodrigo ^a,b   Forlenza, Orestes Vicente ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Lithium; Mood disorders; Safety; Tolerability

Indexed keywords

ACETAZOLAMIDE; ALPRAZOLAM; CAFFEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEVOTHYROXINE; LITHIUM; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL; THEOPHYLLINE; THIAZIDE DIURETIC AGENT;

ABDOMINAL DISCOMFORT; BIPOLAR DISORDER; COGNITIVE DEFECT; DIABETES MELLITUS; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; FATIGUE; GLOMERULUS FILTRATION RATE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERPARATHYROIDISM; HYPOTHYROIDISM; KIDNEY CONCENTRATING CAPACITY; LEUKOCYTE COUNT; MOOD DISORDER; NEUTROPHIL COUNT; NOCTURIA; NONHUMAN; PARATHYROID ADENOMA; PARATHYROID DISEASE; POLLAKISURIA; POLYURIA; PREVALENCE; PROSPECTIVE STUDY; REVIEW; SEVERE RENAL IMPAIRMENT; THYROID ADENOMA; THYROID DISEASE; TREMOR; WEIGHT GAIN; XEROSTOMIA;

EID: 84897564125     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/0101-60830000411914     Document Type: Review

References (91)

1. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17(4):250-260.
2. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217-222.
3. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162(10):1805-1819.
4. Ohgami H, Terao T, Shiotsuki I, Ishii N, Iwata N. Lithium levels in drinking water and risk of suicide. Br J Psychiatry. 2009;194(5):464-465; discussion 46.
5. Forlenza O V, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry. 2011;198(5):351-356.
6. Aggarwal S P, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, et al. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(5):481-488.
7. Yang ML, Li JJ, So KF, Chen JY, Cheng WS, Wu J, et al. Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial. Spinal Cord. 2012;50(2):141-146.
8. Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use? Br J Psychiatry. 2007;191:474-476.
9. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs. 2009;23(5):397-418.
10. Paul R, Minay J, Cardwell C, Fogarty D, Kelly C. Meta-analysis of the effects of lithium usage on serum creatinine levels. J Psychopharmacol. 2010;24(10):1425-1431.
11. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721-728.
12. Mellerup ET, Plenge P. The side effects of lithium. Biol Psychiatry. 1990;28(6):464-466.
13. Rybakowski J, Suwalska A. Gastrointestinal metabolic and body-weight changes during treatment with lithium. UK; 2006.
14. Using lithium safely. Drug Ter Bull. 1999;37(3):22-24.
15. Kleindienst N, Greil W. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder. Psychol Med. 2002;32(3):493-501.
16. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. 2005;162(11):2152-2161.
17. Schou M. Te combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand. 1997;95(5):361-363.
18. Vasile RG, Shelton R P. Alleviating gastrointestinal side effects of lithium carbonate by substituting lithium citrate. J Clin Psychopharmacol. 1982;2(6):420-423.
19. Keck PE. Long-term therapy of bipolar illness. J Fam Pract. 2003;Suppl:S18-21.
20. Ahmad M, Elnakady Y, Farooq M, Wadaan M. Lithium induced toxicity in rats: blood serum chemistry, antioxidative enzymes in red blood cells and histopathological studies. Biol Pharm Bull. 2011;34(2):272-277.
21. Sharma SD, Iqbal M. Lithium induced toxicity in rats: a hemato-logical, biochemical and histopathological study. Biol Pharm Bull. 2005;28(5):834-837.
22. Pogarell O, Folkerts M, Hegerl U. Adverse neurological and neurotoxic effects of lithium therapy. UK; 2006.
23. Honig A, Arts BM, Ponds RW, Riedel WJ. Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. Int Clin Psychopharmacol. 1999;14(3):167-171.
24. Stip E, Dufresne J, Lussier I, Yatham L. A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. J Afect Disord. 2000;60(3):147-157.
25. Pachet AK, Wisniewski AM. Te effects of lithium on cognition: an updated review. Psychopharmacology (Berl). 2003;170(3):225-234.
26. Bell EC, Willson MC, Wilman AH, Dave S, Asghar SJ, Silverstone PH. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. Hum Psychopharmacol. 2005;20(2):87-96.
27. Baptista T, Alastre T, Contreras Q, Martinez JL, Araujo de Baptista E, Burguera JL, et al. Effects of lithium carbonate on reproductive hormones in healthy men: relationship with body weight regulation--a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21(6):937-950.
28. Baptista T, Lacruz A, de Mendoza S, Guillén MM, Burguera JL, de Burguera M, et al. Endocrine effects of lithium carbonate in healthy premenopausal women: relationship with body weight regulation. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24(1):1-16.
29. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol. 2006;20(3):347-55.
30. Berens SC, Bernstein RS, Robbins J, Wolf J. Antithyroid effects of lithium. J Clin Invest. 1970;49(7):1357-1367.
31. Burrow GN, Burke WR, Himmelhoch JM, Spencer RP, Hershman JM. Effect of lithium on thyroid function. J Clin Endocrinol Metab. 1971;32(5):647-652.
32. Lazarus JH. Te effects of lithium therapy on thyroid and thyrotropin--releasing hormone. Tyroid. 1998;8(10):909-913.
33. Kleiner J, Altshuler L, Hendrick V, Hershman JM. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry. 1999;60(4):249-255.
34. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23(6):723-733.
35. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci. 1999;24(3):227-233.
36. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry. 1999;175:336-339.
37. Frye MA, Denicof KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbau-gh D, et al. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Am J Psychiatry. 1999;156(12):1909-1914.
38. Bocchetta A, Bernardi F, Pedditzi M, Loviselli A, Velluzzi F, Martino E, et al. Tyroid abnormalities during lithium treatment. Acta Psychiatr Scand. 1991;83(3):193-198.
39. Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyro-toxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf). 1994;40(6):759-764.
40. Miller KK, Daniels GH. Association between lithium use and thyrotoxico-sis caused by silent thyroiditis. Clin Endocrinol (Oxf). 2001;55(4):501-508.
41. Groleau G. Lithium toxicity. Emerg Med Clin North Am. 1994;12(2):511-531.
42. Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroi-dism: report of four cases and review of the literature. Eur J Endocrinol. 2009;160(2):317-323.
43. Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand. 1995;91(1):48-51.
44. Bendz H, Sjödin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy--a cross-sectional study and the Effect of lithium withdrawal. J Intern Med. 1996;240(6):357-365.
45. Mak T W, Shek CC, Chow CC, Wing YK, Lee S. Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab. 1998;83(11):3857-3859.
46. NICE guideline. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care: quick reference guide; 2006.
47. Grünfeld J.P, Rossier B.C. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5(5):270-276.
48. Eiam-Ong S, Dafnis E, Spohn M, Kurtzman NA, Sabatini S. H-K-ATPase in distal renal tubular acidosis: urinary tract obstruction, lithium, and amiloride. Am J Physiol. 1993;265(6 Pt 2):F875-880.
49. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest. 1995;95(4):1838-1845.
50. Kotnik P, Nielsen J, Kwon TH, Krzisnik C, Frøkiaer J, Nielsen S. Altered expression of COX-1, COX-2, and mPGES in rats with ne-phrogenic and central diabetes insipidus. Am J Physiol Renal Physiol. 2005;288(5):F1053-1068.
51. Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H, et al. Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int. 2003;64(2):585-592.
52. Schou M, Kampf D. Lithium and the kidneys. UK; 2006.
53. Kusalic M, Engelsmann F. Renal reactions to changes of lithium dosage. Neuropsychobiology. 1996;34(3):113-116.
54. Singh LK, Nizamie SH, Akhtar S, Praharaj SK. Improving tolerability of lithium with a once-daily dosing schedule. Am J Ter. 2011;18(4):288-291.
55. Coşkunol H, Vahip S, Mees ED, Başçi A, Bayindir O, Tuǧlulaŕ I. Renal side-effects of long-term lithium treatment. J Afect Disord. 1997;43(1):5-10.
56. Movig KL, Baumgarten R, Leufens HG, van Laarhoven JH, Egberts AC. Risk factors for the development of lithium-induced polyuria. Br J Psychiatry. 2003;182:319-323.
57. Turan T, Eşel E, Tokgöz B, Aslan S, Sofuoǧlu S, Utaş C, et al. Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(3):561-565.
58. Johnson G. Lithium. Med J Aust. 1984;141(9):595-601.
59. Jensen SB, Rickers H. Glomerular filtration rate during lithium therapy. A longitudinal study. Acta Psychiatr Scand. 1984;70(3):235-238.
60. Løkkegaard H, Andersen NF, Henriksen E, Bartels PD, Brahm M, Baastrup PC, et al. Renal function in 153 manic-depressive patients treated with lithium for more than fve years. Acta Psychiatr Scand. 1985;71(4):347-355.
61. Waller DG, Edwards JG, Papasthatis-Papayanni S. A longitudinal assessment of renal function during treatment with lithium. Q J Med. 1988;68(255):553-558.
62. Schou M. Serum lithium monitoring of prophylactic treatment. Critical review and updated recommendations. Clin Pharmacokinet. 1988;15(5):283-286.
63. Povlsen UJ, Hetmar O, Ladefoged J, Bolwig TG. Kidney functioning during lithium treatment: a prospective study of patients treated with lithium for up to ten years. Acta Psychiatr Scand. 1992;85(1):56-60.
64. Bendz H, Aurell M, Balldin J, Mathé AA, Sjödin I. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant. 1994;9(9):1250-4.
65. Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. Eur Psychiatry. 2001;16(4):199-206.
66. Lepkifer E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M. Renal insuf-ciency in long-term lithium treatment. J Clin Psychiatry. 2004;65(6):850-856.
67. Bassilios N, Martel P, Godard V, Froissart M, Grünfeld J P, Stengel B, et al. Monitoring of glomerular filtration rate in lithium-treated outpatients---an ambulatory laboratory database surveillance. Nephrol Dial Transplant. 2008;23(2):562-565.
68. McCann SM, Daly J, Kelly CB. The impact of long-term lithium treatment on renal function in an outpatient population. Ulster Med J. 2008;77(2):102-105.
69. Janowsky DS, Soares J, Hatch J P, Zunta-Soares G, Hu Q, Davis JM. Lithium Effect on renal glomerular function in individuals with intellectual disability. J Clin Psychopharmacol. 2009;29(3):296-299.
70. Bendz H, Schön S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77(3):219-224.
71. Tredget J, Kirov A, Kirov G. Effects of chronic lithium treatment on renal function. J Afect Disord. 2010;126(3):436-440.
72. Sadoul JL, Kezachian B, Freychet P. [Lithium therapy and hyperthyroi-dism: disease caused or facilitated by lithium? Review of the literature apropos of a case of hyperthyroidism preceded by transient hypothyroi-dism]. Ann Endocrinol (Paris). 1994;54(5):353-358.
73. Massey EW, Folger WN. Seizures activated by therapeutic levels of lithium carbonate. South Med J. 1984;77(9):1173-1175.
74. Bierbrauer J, Albrecht J, Müller-Oerlinghausen B. Lithium and its cardiovascular effects. UK; 2006.
75. Kusalic M, Engelsmann F. Effect of lithium maintenance treatment on hypothalamic pituitary gonadal axis in bipolar men. J Psychiatry Neu-rosci. 1996;21(3):181-186.
76. Inayat M, Gallicchio V. The effects of lithium on the immune system. UK; 2006.
77. Vendsborg PB, Bach-Mortensen N, Rafaelsen OJ. Fat cell number and weight gain in lithium treated patients. Acta Psychiatr Scand. 1976;53(5):355-359.
78. Kuruvilla PK, Alexander J. Lithium toxicity presenting as non-convulsive status epilepticus (NCSE). Aust N Z J Psychiatry. 2001;35(6):852.
79. Vestergaard P, Schou M. Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology. 1987;17(3):130-132.
80. Baştürk M, Karaaslan F, Esel E, Sofuoǧlu S, Tutuş A, Yabanoǧlu I. Effects of short and long-term lithium treatment on serum prolactin levels in patients with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25(2):315-322.
81. El Khoury A, Tam A, Mathé AA, Aberg-Wistedt A, Stain-Malmgren R. Decreased plasma prolactin release in euthymic lithium-treated women with bipolar disorder. Neuropsychobiology. 2003;48(1):14-18.
82. Bellesi M, Passamonti L, Silvestrini M, Bartolini M, Provinciali L. Non-convulsive status epilepticus during lithium treatment at therapeutic doses. Neurol Sci. 2006;26(6):444-446.
83. Yip KK, Yeung WT. Lithium overdose causing non-convulsive status epilepticus--the importance of lithium levels and the electroencephalo-graphy in diagnosis. Hong Kong Med J. 2007;13(6):471-474.
84. Gansaeuer M, Alsaadi TM. Lithium intoxication mimicking clinical and electrographic features of status epilepticus: a case report and review of the literature. Clin Electroencephalogr. 2003;34(1):28-31.
85. Farres MT, Ronco P, Saadoun D, Remy P, Vincent F, Khalil A, et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology. 2003;229(2):570-574.
86. Tuazon J, Casalino D, Syed E, Batlle D. Lithium-associated kidney mi-crocysts. ScientifcWorldJournal. 2008;8:828-829.
87. Roque A, Herédia V, Ramalho M, de Campos R, Ferreira A, Azevedo R, et al. MR findings of lithium-related kidney disease: preliminary observations in four patients. Abdom Imaging. 2012;37(1):140-146.
88. Baethge C, Blumentritt H, Berghöfer A, Bschor T, Glenn T, Adli M, et al. Long-term lithium treatment and thyroid antibodies: a controlled study. J Psychiatry Neurosci. 2005;30(6):423-427.
89. Diebold K, Michel G, Schweizer J, Diebold-Dörsam M, Fiehn W, Kohl B. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders? Pharmacopsychiatry. 1998;31(2):60-67.
90. Kortenoeven M.L, Li Y, Shaw S, Gaeggeler H.P, Rossier B.C, Wetzels J.F, et al. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int. 2009;76(1):44-53.
91. Kaplan P W, Birbeck G. Lithium-induced confusional states: non-convulsive status epilepticus or triphasic encephalopathy? Epilepsia. 2006;47(12):2071-2074.